116 related articles for article (PubMed ID: 1810411)
1. Preparations of phosphonate, phosphoramidate and phosphate derivatives and their evaluation as transdermal penetration enhancers.
Aoyagi T; Yamamura M; Matsui K; Nagase Y
Drug Des Discov; 1991 Nov; 8(1):47-56. PubMed ID: 1810411
[TBL] [Abstract][Full Text] [Related]
2. Preparation of alkyl-substituted pyrrolidone derivatives and their evaluation as transdermal penetration enhancers.
Aoyagi T; Yamamura M; Suzuki N; Matsui K; Nagase Y
Drug Des Discov; 1991 Nov; 8(1):37-46. PubMed ID: 1810410
[TBL] [Abstract][Full Text] [Related]
3. Preparations of cyclic sulfoxide derivatives and their evaluation as transdermal penetration enhancers.
Aoyagi T; Yamamura M; Matsui K; Nagase Y
Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1961-3. PubMed ID: 1394720
[TBL] [Abstract][Full Text] [Related]
4. Investigating the activity of 2-substituted alkyl-6-(2,5-dioxopyrrolidin-1-yl)hexanoates as skin penetration enhancers.
Brychtova K; Opatrilova R; Raich I; Kalinowski DS; Dvorakova L; Placek L; Csollei J; Richardson DR; Jampilek J
Bioorg Med Chem; 2010 Dec; 18(24):8556-65. PubMed ID: 21055950
[TBL] [Abstract][Full Text] [Related]
5. Transdermal delivery of penetrants with differing lipophilicities using O-acylmenthol derivatives as penetration enhancers.
Zhao L; Fang L; Xu Y; Liu S; He Z; Zhao Y
Eur J Pharm Biopharm; 2008 May; 69(1):199-213. PubMed ID: 18065216
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, physico-chemical properties and penetration activity of alkyl-6-(2,5-dioxopyrrolidin-1-yl)-2-(2-oxopyrrolidin-1-yl)hexanoates as potential transdermal penetration enhancers.
Brychtova K; Jampilek J; Opatrilova R; Raich I; Farsa O; Csollei J
Bioorg Med Chem; 2010 Jan; 18(1):73-9. PubMed ID: 19954983
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of1',2'-seconucleo-5'- phosphonates.
Racha S; Vargeese C; Vemishetti P; El-Subbagh HI; Abushanab E; Panzica RP
J Med Chem; 1996 Mar; 39(5):1130-5. PubMed ID: 8676349
[TBL] [Abstract][Full Text] [Related]
8. Formulation development of transdermal dosage forms: quantitative structure-activity relationship model for predicting activities of terpenes that enhance drug penetration through human skin.
Kang L; Yap CW; Lim PF; Chen YZ; Ho PC; Chan YW; Wong GP; Chan SY
J Control Release; 2007 Jul; 120(3):211-9. PubMed ID: 17582639
[TBL] [Abstract][Full Text] [Related]
9. Promoting effect of 2-n-alkylcyclohexanones on the percutaneous absorption of indomethacin.
Quan D; Higuchi RI; Takayama K; Higashiyama K; Nagai T
Drug Des Deliv; 1989 Dec; 5(2):149-57. PubMed ID: 2577985
[TBL] [Abstract][Full Text] [Related]
10. The effect of penetration enhancers on drug delivery through skin: a QSAR study.
Ghafourian T; Zandasrar P; Hamishekar H; Nokhodchi A
J Control Release; 2004 Sep; 99(1):113-25. PubMed ID: 15342185
[TBL] [Abstract][Full Text] [Related]
11. Transdermal delivery of indomethacin: II. Effect of penetration enhancers on the in vitro percutaneous absorption from patch formulations.
Kanikkannan N; Jayaswal SB; Singh J
Pharmazie; 1994 Aug; 49(8):619-20. PubMed ID: 7938156
[No Abstract] [Full Text] [Related]
12. Moisturizing lotions can increase transdermal absorption of the herbicide 2,4-dichlorophenoxacetic acid across hairless mouse skin.
Brand RM; Charron AR; Sandler VL; Jendrzejewski JL
Cutan Ocul Toxicol; 2007; 26(1):15-23. PubMed ID: 17464745
[TBL] [Abstract][Full Text] [Related]
13. Effect of O-acylmenthol on transdermal delivery of drugs with different lipophilicity.
Zhao L; Fang L; Xu Y; Zhao Y; He Z
Int J Pharm; 2008 Mar; 352(1-2):92-103. PubMed ID: 18053661
[TBL] [Abstract][Full Text] [Related]
14. Enhancing effect of pyrrolidone derivatives on transdermal penetration of phenolsulfonphthalein and indomethacin from aqueous vehicle.
Sasaki H; Kojima M; Nakamura J; Shibasaki J
Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):797-9. PubMed ID: 2347025
[TBL] [Abstract][Full Text] [Related]
15. Microemulsions as transdermal drug delivery vehicles.
Kogan A; Garti N
Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and transdermal permeation-enhancing activity of carbonate and carbamate analogs of Transkarbam 12.
Holas T; Vávrová K; Síma M; Klimentová J; Hrabálek A
Bioorg Med Chem; 2006 Dec; 14(23):7671-80. PubMed ID: 16942882
[TBL] [Abstract][Full Text] [Related]
17. Enhancing effect of piperidone derivatives on the percutaneous absorption of indomethacin.
Quan DY; Higuchi RI; Takayama K; Higashiyama K; Nagai T
Drug Des Deliv; 1990 May; 6(1):61-71. PubMed ID: 2078287
[TBL] [Abstract][Full Text] [Related]
18. Enhanced transdermal delivery of atenolol from the ethylene-vinyl acetate matrix.
Cho CW; Shin SC
Int J Pharm; 2004 Dec; 287(1-2):67-71. PubMed ID: 15541913
[TBL] [Abstract][Full Text] [Related]
19. Enhanced transdermal delivery of loratadine from the EVA matrix.
Cho CW; Choi JS; Kim SJ; Shin SC
Drug Deliv; 2009 May; 16(4):230-5. PubMed ID: 19514983
[TBL] [Abstract][Full Text] [Related]
20. New alkyl N,N-dialkyl-substituted amino acetates as transdermal penetration enhancers.
Wong O; Huntington J; Nishihata T; Rytting JH
Pharm Res; 1989 Apr; 6(4):286-95. PubMed ID: 2748516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
